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ABSTRACT
Objectives: This study aims to investigate if cardiac involvement may occur in children with familial Mediterranean fever (FMF) without 
cardiovascular symptoms by using heart rate recovery (HRR) and systolic blood pressure recovery (SBPR) parameters.
Patients and methods: A total of 50 FMF patients (26 males, 24 females; mean age 151±33.4 month; range 60 to 216 month) and 30 healthy 
controls (18 males, 12 females; mean age 143±43.9 month; range 84 to 228 month) were included in the study. All patients were evaluated by 
echocardiography. All patients underwent a maximal graded exercise stress test. HRR and SBPR parameters were calculated.
Results: There was a significant decrease in HRR1 value in FMF group (p=0.03). SBPR1 and SPBR2 values were higher in FMF group compared to 
control group (0.96±0.12 vs 0.88±0.12 and 0.95±0.09 vs 0.91±0.11, respectively); and the high SBPR1 value was statistically significant (p=0.02). 
FMF presence had a negative correlation with HRR1 (r= -0.26, p=0.03) and a positive correlation with SBPR1 (r=0.29, p=0.02). There was a negative 
correlation of M694V homozygous mutation with HRR1 and HRR2 values (r= -0.43, p=0.004, r=-0.42, p=0.005).
Conclusion: Cardiac involvement may occur in FMF patients without cardiovascular symptoms. Impaired SBPR and decreased HRR response may 
indicate increased cardiovascular risk in these patients despite normal exercise stress test results.
Keywords: Autonomic dysfunction; Familial Mediterranean fever; heart rate recovery; systolic blood pressure recovery.
Familial Mediterranean fever (FMF) is an 
autosomal recessive auto inflammatory disease 
characterized by recurrent fever attacks 
and inflammation of the serous membranes 
(peritonitis, pleuritis, pericarditis, arthritis, etc.).1 
Cardiovascular involvement is one of the major 
causes of mortality and morbidity in patients 
with FMF.2
The exercise stress test has been used to assess 
the cardiovascular performance of patients. Besides 
exercise capacity and chronotropic response, 
heart rate recovery (HRR) index and systolic blood 
pressure recovery (SBPR) rate can be calculated 
by the exercise stress test.3,4 A normal HRR 
response occurs as a result of a balance between 
sympathetic and parasympathetic systems. The 
presence of abnormal HRR has been shown to 
be an independent marker of mortality. Increased 
sympathetic activity and delayed HRR response 
due to insufficient vagal reactivation have been 
shown as autonomic dysfunction findings in FMF 
patients.5,6 SBPR can be obtained by determining 
the ratio of the third-minute systolic blood pressure 
of the recovery period to peak exercise systolic 
blood pressure, or the first-minute systolic blood 
pressure. It represents the reduction in systolic 
blood pressure after exercise.7,8 A delay in the 
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reduction of systolic blood pressure after exercise 
is an abnormal response and has been associated 
with increased cardiovascular risk.9 There have 
been studies in the literature demonstrating 
abnormal HRR findings in FMF patients. To 
the best of our knowledge, no study has been 
conducted on individuals with FMF using SBPR, 
which is known to be associated with increased 
cardiovascular risk. Therefore, in this study, we 
aimed to investigate if cardiac involvement may 
occur in children with FMF without cardiovascular 
symptoms by using HRR and SBPR parameters.
PATIENTS AND METHODS
This study was conducted by the Pamukkale 
University’s Medical Faculty Pediatric 
Rheumatology Department and Cardiology 
Department between January 2015 and 
June 2015. A total of 50 patients (26 males, 
24 females; mean age 151±33.4 month; range 
60 to 216 month) who were not in attack period 
and were being followed-up with a FMF diagnosis 
according to Tel Hashomer and a new set of 
criteria for children10,11 were included. In addition, 
30 healthy controls (18 males, 12 females; mean 
age 143±43.9 month; range 84 to 228 month) 
with no cardiologic or rheumatologic problems 
were included. Those with comorbid secondary 
chronic rheumatic problems to a FMF diagnosis 
were excluded. The onset age of disease, disease 
duration, clinical findings (fever, abdominal pain, 
chest pain, joint pain, and rash), dose and 
duration of medication, and Mediterranean fever 
mutation were recorded for each patient. All 
patients were evaluated by echocardiography 
before the study to eliminate congenital heart 
defects. The study protocol was approved by 
the Pamukkale University’s Medical Faculty 
Ethics Committee. The study was conducted in 
accordance with the principles of the Declaration 
of Helsinki.
The patients and control group underwent 
a maximal graded exercise stress test using 
a Quinton treadmill system with the modified 
Bruce technique developed for children.12 The 
12-lead electrocardiographic monitorization 
was performed continuously during the test. 
Blood pressure and heart rate were measured 
automatically using a Tango exercise blood 
pressure-monitoring device before every stage and 
at the second minute in every stage of the exercise 
stress test. Maximal target heart rate during the 
exercise stress test was calculated as subtraction 
of age (year) from 220. The exercise stress test 
was continued until reaching 95% of the maximal 
heart rate. The HRR differences within the first 
five minutes after exercise (HRR1, HRR2, HRR3, 
HRR4, and HRR5) were calculated by subtracting 
the heart rate at each minute from the maximal 
heart rate. The ratio of the third-minute systolic 
blood pressure (SBP) of recovery period to peak 
SBP was considered to be SBPR1. Additionally, 
the ratio of the third-minute SBP of recovery 
period to the first-minute SBP was considered to 
be SBPR2.8 When the exercise capacity reached 
peak exercise, it was calculated as the total 
metabolic equivalent units.
Statistical analysis
All data were evaluated using the SPSS version 
16.0 software (SPSS Inc., Chicago, IL, USA). 
Continuous variables were expressed as mean ± 
standard deviation and categorical variables were 
expressed as percentages. The Chi-square test and 
unpaired t test were used for evaluating comparisons 
of categorical and continuous variables between 
the two groups. Correlations between HRR and 
SBPR parameters were calculated by the Pearson’s 
correlation analysis. A p value of ≤0.05 was 
considered statistically significant.
RESULTS
All of the children’s growth-development and 
physical examinations were normal. The mean 
age, height, and weight of FMF and control 
groups were similar ([151±33.4 month, 143±43.9 
month p=0.46], [151±15.9 cm, 148±17.5 cm 
p=0.46], and [44.5±14.6 kg, 42.6±15.2 kg p=0.5], 
respectively). The most common clinical symptoms 
observed in the FMF group were abdominal 
pain (86%) and fever (62%). The clinical findings 
of FMF are presented in Table 1. All patients 
underwent genetic analysis for the Mediterranean 
fever mutation. The M694V mutation was the most 
commonly obtained mutation (32%). Comparison 
of the exercise stress test parameters of FMF and 
control groups is summarized in Table 2. Although 
all HRR parameters obtained were lower in the 
FMF group compared to the control group, there 
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was a significant decrease in the HRR1 value 
(p=0.03). In addition, the SBPR1 and SPBR2 values 
obtained were higher in the FMF group compared 
to the control group (0.96±0.12 vs. 0.88±0.12 
and 0.95±0.09 vs. 0.91±0.11, respectively); and 
the high SBPR1 value was statistically significant 
(p=0.02). Other exercise stress test parameters 
were similar between both groups.
The FMF clinical findings and correlation 
analysis results among the exercise stress test 
parameters are summarized in Table 3. The FMF 
presence had a negative correlation with HRR1 
(r= -0.26, p=0.03), but a positive correlation with 
SBPR1 (r=0.29, p=0.02). Moreover, there was a 
negative correlation of the M694V homozygous 
mutation with the HRR1 and the HRR2 values 
(r= -0.43, p=0.004; and r= -0.42, p=0.005). 
There was no correlation of the HRR and 
the SBPR values with age and daily dose of 
colchicine.
DISCUSSION
In this study, we detected deteriorated exercise 
stress test parameters in children with FMF. 
Table 1. Demographic and clinical features of patients with familial 
Mediterranean fever
Age (month)   151±33.4
Height (centimeter)   151.4±15.9
Weight (kg)   44.5±14.6
Age at diagnosis (month)   100±39
Disease duration (month   49.9±26.8
Dose of colchicine (mg/day)   1.1±0.21
Clinical manifestation
Fever 31 62
Abdominal pain 43 86






Compound heterozygous 17 34
No mutation 2 4
SD: Standard deviation.
 n % Mean±SD
Table 2. Comparison of exercise stress test characteristics between patient and control groups
Exercise capacity (METs) 11±1.5 11.1±1.3 0.745
Preexercise SBP (mmHg) 118±14.6 117±18 0.813
Preexercise DBP (mmHg) 75±13 73±13 0.711
Peak exercise HR, beats/min 172±17 173±17 0.804
Peak SBP (mmHg) 132±21 137±18 0.330
Peak DBP (mmHg) 74±14 68±16 0.213
Recovery SBP 1st min (mmHg) 133±21 132±19 0.893
Recovery SBP 3rd min (mmHg) 125±15 119±15 0.148
SBPR1 0.96±0.12 0.88±0.12 0.020
SBPR2 0.95±0.09 0.91±0.11 0.17
HRR 1st min, beats/min 48±14 57±20 0.035
HRR 2nd min, beats/min 63±13 71±20 0.077
HRR 3rd min, beats/min 65±13 71±17 0.110
HRR 4th min, beats/min 67±11 72±17 0.203
HRR 5th min, beats/min 69±12 71±13 0.531
FMF: Familial Mediterranean fever; SD: Standard deviation; METs: Metabolic equivalent units; SBP: Systolic blood pressure; 
DBP: Diastolic blood pressure; HR: Heart rate; SBPR: Systolic blood pressure recovery; HRR: Heart rate recovery.
 FMF patients Controls
 Mean±SD Mean±SD p
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Firstly, the HRR1 value was decreased in children 
with FMF compared to the control group. 
Secondly, the SBPR1 value was significantly 
increased in children with FMF. Thirdly, a 
negative correlation was found between FMF 
presence and HRR1, but a positive correlation 
was found between SBPR1 and FMF presence. 
Lastly, the presence of an M694V homozygous 
mutation was negatively correlated between 
HRR1 and HRR2 values.
The autonomic nervous system plays a major 
role in the regulation of cardiovascular functions. 
Studies in the literature have investigated the 
relationship between autoinflammatory diseases 
and cardiac autonomic dysfunction.13,14 HRR 
is a frequently used technique for assessing 
cardiac autonomic dysfunction.15 Deterioration 
was found in the HRR indexes of adult patients 
with FMF compared to healthy individuals in 
recent studies that Ardic5 and Canpolat et al.6 
conducted. Contrary to these studies, Sahin et 
al.16 found no difference between groups in terms 
of HRR parameters in their study conducted on 
children patients. In our study, deterioration was 
found in the HRR1 value for children with FMF 
compared to the healthy control group. These 
controversial results between Sahin et al.16 and 
our study may arise from the different clinical 
and genotypical characteristics of the patient 
populations. While M694V mutation prevalence 
was 17% in their study, it was 32% in our study 
group. Also, the mean age of our patients was 
higher than in Sahin’s study group.
Cardiovascular complications contribute to the 
morbidity and mortality rates in rheumatologic 
and autoinflammatory diseases. An insufficient 
reduction in heart rate after exercise has been 
shown to be a marker of autonomic dysfunction.17 
In addition, it has been documented as an 
independent indicator of all mortalities caused 
by cardiovascular and other diseases.18,19 
This autonomic dysfunction, characterized by 
insufficient vagal reactivation besides excessive 
sympathetic activation, has been associated with 
FMF.20,21 Moreover, deteriorated HRR at the 
first minute after exercise is a powerful marker 
of mortality, independent from the increased 
workload of the heart during exercise, and 
myocardial perfusion defects.22
Changes in SBPR have been proposed to be 
associated with sympathetic and parasympathetic 
activity, systemic vascular resistance, and 
baroreflex sensitivity. A decreased SBP ratio 
after exercise has been considered to be a 
reflection of the physical activity and general 
health of an individual. A greater decrease in 
SBP in the recovery period after peak exercise 
reflects that the individual’s physical activity 
and aerobic capacity are good. This response 
occurs as a result of a reduction in systemic 
vascular resistance because exercise improves 
vascular endothelial function and vasodilator 
capability.23-27
In several recent studies, markers indicating 
endothelial damage, such as thrombomodulin, 
adrenomedullin, and nitrite, have been found 
to be high in FMF patients in the non-attack 
period as well.28,29 This finding proposes that 
ongoing subclinical inflammation and endothelial 
dysfunction are present also in the non-attack 
period in patients, and this is associated with 
increased cardiovascular problems.30 We think that 
endothelial and autonomic dysfunction, together 
with subclinical inflammation, are responsible 
Table 3. Correlation analysis between clinical characteristics of familial Mediterranean fever patients and exercise stress 
test characteristics
SBPR1 0.294 0.020 0.047 0.715 -0.144 0.416 0.248 0.090
SBPR2 0.176 0.172 0.105 0.417 0.147 0.405 0.116 0.428
HRR 1st min, beats/min -0.269 0.035 0.080 0.537 -0.074 0.677 -0.430 0.004
HRR 2nd min, beats/min -0.227 0.077 0.098 0.447 0.058 0.744 -0.421 0.005
HRR 3rd min, beats/min -0.205 0.110 0.163 0.206 0.101 0.572 -0.068 0.645
HRR 4th min, beats/min -0.164 0.203 0.145 0.262 0.064 0.720 -0.158 0.285
HRR 5th min, beats/min -0.081 0.531 0.134 0.299 0.131 0.462 -0.014 0.927
FMF: Familial Mediterranean fever; SBPR: Systolic blood pressure recovery; HRR: Heart rate recovery; Correlation coefficients: r value.
 Existence FMF Age Daily dose of colchicine M694V homozygous
 r p r p r p r p
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for a significantly higher SBPR1 value in FMF 
patients compared to the control group.
Although insufficient HRR and autonomic 
dysfunction are well known, there has been 
limited information demonstrating the relationship 
between SBPR and the autonomic nervous 
system.31 Therefore, the demonstration of an 
insufficient SBPR1 response for the first time in 
FMF patients might be significant for indicating 
autonomic and endothelial dysfunction, which 
has been shown to be associated with FMF 
pathophysiology.
Considering the correlation analysis of clinical 
findings and the exercise stress test parameters 
of FMF patients, the presence of disease had a 
negative correlation with HRR1, and a positive 
correlation with SBPR1 also supported this 
finding. In addition, the negative correlation 
between HRR1 and HRR2 values in M694V 
mutation-positive patients was considered to be 
responsible for disease coursing with severe 
clinical symptoms.32,33 This suggests that 
M694V homozygote patients have an increased 
cardiovascular risk.
The exercise capacities of the patient and 
control groups were good. No significant 
difference was found in terms of exercise capacity, 
initial heart rate, and peak heart rate. Therefore, 
we suggest that insufficiency in HRR and SBPR 
developed due to autonomic and endothelial 
dysfunction.
One of the limitations of this study was the 
limited number of patients. In addition, we do not 
know the exact effect of FMF SBPR. Therefore, 
further studies are necessary to identify SBPR 
correctly after exercise stress tests in patients with 
FMF.
In conclusion, to our knowledge, this is the 
first study indicating SBPR impairment and 
its relationship to the HRR of patients with 
FMF. Cardiac involvement may occur in FMF 
patients without cardiovascular symptoms. FMF 
is associated with insufficient SBPR and delayed 
HRR after exercise. In our opinion, insufficient 
SBPR and decreased HRR response may indicate 
increased cardiovascular risk in these patients 
despite normal exercise stress tests. Further 
studies are necessary to demonstrate the clinical 
findings of deteriorated autonomic and endothelial 
dysfunction in FMF patients, and to explain the 
exact underlying pathophysiological mechanisms 
in autoinflammatory diseases.
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